TOWSE MATTHEW W 4
4 · NxStage Medical, Inc. · Filed Jul 21, 2017
Insider Transaction Report
Form 4
TOWSE MATTHEW W
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2017-07-20$14.05/sh+4,300$60,415→ 28,721 total - Sale
Common Stock
2017-07-20$24.16/sh−4,300$103,888→ 24,421 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-07-20−4,300→ 12,630 totalExercise: $14.05From: 2014-07-15Exp: 2023-07-14→ Common Stock (4,300 underlying)
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2016.